Cream with endocannabinoids effective in the treatment of pruritus due to kidney disease (news – 2005)                              


Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells (full – 2006)                               


Regulation of Bone Mass, Osteoclast Function, and Ovariectomy-Induced Bone Loss by the Type 2 Cannabinoid Receptor                                                             (full – 2008)  ulltext=cannabinoid&searchid=1&FIRSTINDEX=240&resourcetype=HWCIT


The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney. (abst – 2008)                                 


Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4                                                                               (full – 2009)  annabis&searchid=1&FIRSTINDEX=2400&resourcetype=HWCIT


The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.                                                    (full – 2009)


Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy       (full – 2010)


Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.  (full – 2010)


Expression of cannabinoid receptors in human kidney.                     (abst – 2010)


Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death                                                                    (full – 2011)









Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.                                              (full – 2011)


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                        


Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy.     (full – 2011)                          


Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease.                                                    (abst – 2011)


Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease?                                                                 (abst – 2011)


Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance.  (abst – 2011)                             


β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.                                                         (abst – 2012)


Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats. (abst – 2012)                             


AKI Associated with Synthetic Cannabinoids: A Case Series.             (abst – 2012)


Outbreak of kidney failure in Wyoming linked to “Spice”                (news – 2012)


Wyoming kidney failure outbreak linked to designer ‘blueberry spice’ drug, aka ‘legal marijuana’  (news – 2012)


Blueberry “spice” in Wyoming linked to cases of renal failure                  (news – 2012)


New health concerns about ‘fake pot’ in US              (news – 2012)


Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012          (report – 2013)              


Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis. (abst – 2013)                              










Synthetic Marijuana Dangerous for Kidneys                      (news – 2013)


Synthetic Marijuana Harms Kidneys of 16 Users, CDC Reports                      (news – 2013)

Share a link for